Business Daily Media

Business Marketing

Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

  • Written by ACN Newswire - Press Releases

Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

TOKYO and KENILWORTH, N.J., Jul 23, 2021 - (JCN Newswire) - Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the U.S. Food and Drug Administration (FDA) has approved the combination of LENVIMA, the orally available multiple receptor tyrosine kinase

Read more //?#

Popular

Avoiding industry tricks and traps as Australians embrace Buy Now, Pay Later

Gimmie co-founders, Scott Roworth and Nadine Tuckey Australia’s most flexible and transparent Buy Now, Pay Later online marketplace, Gimmie, commissioned consumer research examining attitudes and sentiment toward consumer borro...

8 reasons why advertising your new business is a must

Advertising plays a key role in the success of a business. No matter whether you are starting a small business or a giant entity, it’s necessary to advertise it to make it successful. Advertising is a sort of important and dir...

Setting your business apart from the crowd using CGI technologies and solutions

Content is king. A phrase we’ve heard over and over again. But market leaders are increasingly turning to clever, faster and more memorable ways to communicate. What does that mean and how is it effective?  In the constantly...

Virtual Office
Tomorrow Business Growth